The evidence supporting the early treatment for type 1 retinopathy of prematurity needs further evaluation [1]

Archives of Ophthalmology

Volumn 123, Issue 3, 2005, Pages 406-

  Averbukh, Edward ^a  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

CALCULATION; EVIDENCE BASED MEDICINE; FUNCTIONAL ASSESSMENT; HUMAN; INTERNATIONAL CLASSIFICATION OF DISEASES; LETTER; OUTCOMES RESEARCH; PRACTICE GUIDELINE; PREMATURITY; PRIORITY JOURNAL; RESPIRATORY TRACT DISEASE; RETROLENTAL FIBROPLASIA; RISK ASSESSMENT; STATISTICAL SIGNIFICANCE; TREATMENT FAILURE; CLASSIFICATION; LASER COAGULATION; NEWBORN; NOTE; RETINA DETACHMENT; VISUAL ACUITY;

HUMANS; INFANT, NEWBORN; LASER COAGULATION; RETINAL DETACHMENT; RETINOPATHY OF PREMATURITY; VISUAL ACUITY;

EID: 14944345417     PISSN: 00039950     EISSN: 00039950     Source Type: Journal    
DOI: 10.1001/archopht.123.3.406-a     Document Type: Letter

References (1)

1. Early Treatment for Retinopathy of Prematurity Cooperative Group. Revised indications for the treatment of retinopathy of prematurity: results of the early treatment for retinopathy of prematurity randomized trial. Arch Ophthalmol. 2003;121:1684-1694.